Bellevue Healthcare Trust
| Formerly | BB Healthcare Trust |
|---|---|
| Company type | Public company |
| LSE: BBH | |
| Industry | Investment Management |
| Founded | 2016 |
| Headquarters | , |
Area served | Worldwide |
Key people | Randeep Grewal (Chairman) Paul Major and Brett Darke (managers) |
| Website | www |
Bellevue Healthcare Trust is a large British investment trust dedicated to investments in listed or quoted healthcare companies on a worldwide basis. It is listed on the London Stock Exchange.
History
The company was launched on the basis of a prospectus issued on 10 November 2016.[1][2]
The company changed its name from BB Healthcare Trust to Bellevue Healthcare Trust, to establish consistency with the name of its investment manager, on 3 March 2022.[3]
Investment activity
The company is managed by Paul Major and Brett Darke of Bellevue Asset Management (UK) Limited and the chairman is Randeep Grewal.[4]
The company's largest investments as at 31 November 2021 were as follows:[5]
| Ranking | Company | Valuation (£'m) |
|---|---|---|
| 1 | Vertex Pharmaceuticals | 79.1 |
| 2 | Jazz Pharmaceuticals | 75.8 |
| 3 | Insmed | 71.5 |
| 4 | Anthem | 58.5 |
| 5 | Humana | 55.2 |
References
- ^ "BB Healthcare Trust". Trust.net. Retrieved 3 June 2020.
- ^ "Bellevue Asset Management plans £200m investment trust IPO on London Stock Exchange". City AM. Retrieved 27 September 2022.
- ^ "BB Healthcare Trust Plc. – Company Name Change". Pilling & Co. 3 March 2022. Retrieved 18 March 2022.
- ^ "Fund manager Randeep Grewal appointed new chairman of BB Healthcare". Proactive Investors. 17 July 2019. Retrieved 3 June 2020.
- ^ "Annual Report 2021" (PDF). Bellevue Healthcare Trust. Retrieved 27 September 2022.